SAVANNAH RACHEL: Open Payments
NPI 1396421871 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$839 in 46 payments from 19 companies in 2025. Trend: 2023 $284 · 2024 $1,332 · 2025 $839
Food & beverage: $839
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $158 |
| Lilly USA, LLC | 8 | $125 |
| Exact Sciences Corporation | 5 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
| Edwards Lifesciences Corporation | 1 | $40 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| Abbott Laboratories | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $24 |
Products named: MOUNJARO, Cologuard Collection Kit, Ozempic, Kerendia, REXULTI, Wegovy, Rybelsus, GARDASIL 9.
Industry payments across LA — which companies pay providers there.
